XTANT MEDICAL HOLDINGS INC (XTNT) Stock Fundamental Analysis

NYSEARCA:XTNT • US98420P3082

0.5876 USD
+0.01 (+1.29%)
Last: Feb 23, 2026, 08:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

XTNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. XTNT may be in some trouble as it scores bad on both profitability and health. XTNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year XTNT was profitable.
  • In the past year XTNT had a positive cash flow from operations.
  • XTNT had negative earnings in 4 of the past 5 years.
  • XTNT had negative operating cash flow in 4 of the past 5 years.
XTNT Yearly Net Income VS EBIT VS OCF VS FCFXTNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • XTNT has a Return On Assets of -4.43%. This is in the better half of the industry: XTNT outperforms 67.57% of its industry peers.
  • XTNT's Return On Equity of -9.44% is fine compared to the rest of the industry. XTNT outperforms 67.57% of its industry peers.
  • The Return On Invested Capital of XTNT (0.03%) is better than 63.78% of its industry peers.
Industry RankSector Rank
ROA -4.43%
ROE -9.44%
ROIC 0.03%
ROA(3y)-10.3%
ROA(5y)-11.34%
ROE(3y)-20.61%
ROE(5y)-25.18%
ROIC(3y)N/A
ROIC(5y)N/A
XTNT Yearly ROA, ROE, ROICXTNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

  • The Operating Margin of XTNT (0.02%) is better than 63.78% of its industry peers.
  • XTNT has a Gross Margin of 60.16%. This is in the better half of the industry: XTNT outperforms 61.62% of its industry peers.
  • In the last couple of years the Gross Margin of XTNT has declined.
Industry RankSector Rank
OM 0.02%
PM (TTM) N/A
GM 60.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-2.41%
XTNT Yearly Profit, Operating, Gross MarginsXTNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • XTNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, XTNT has more shares outstanding
  • XTNT has more shares outstanding than it did 5 years ago.
  • XTNT has a worse debt/assets ratio than last year.
XTNT Yearly Shares OutstandingXTNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XTNT Yearly Total Debt VS Total AssetsXTNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • Based on the Altman-Z score of -0.81, we must say that XTNT is in the distress zone and has some risk of bankruptcy.
  • XTNT has a Altman-Z score of -0.81. This is comparable to the rest of the industry: XTNT outperforms 44.32% of its industry peers.
  • A Debt/Equity ratio of 0.46 indicates that XTNT is not too dependend on debt financing.
  • XTNT has a Debt to Equity ratio (0.46) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACC0
WACC11.17%
XTNT Yearly LT Debt VS Equity VS FCFXTNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 2.47 indicates that XTNT has no problem at all paying its short term obligations.
  • XTNT has a Current ratio (2.47) which is in line with its industry peers.
  • A Quick Ratio of 1.16 indicates that XTNT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.16, XTNT is doing worse than 69.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.16
XTNT Yearly Current Assets VS Current LiabilitesXTNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • XTNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.69%, which is quite impressive.
  • XTNT shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.44%.
  • Measured over the past years, XTNT shows a quite strong growth in Revenue. The Revenue has been growing by 12.64% on average per year.
EPS 1Y (TTM)107.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)28.44%
Revenue growth 3Y28.5%
Revenue growth 5Y12.64%
Sales Q2Q%19.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.30% on average over the next years. This is a very strong growth
  • XTNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.69% yearly.
EPS Next Y121.25%
EPS Next 2Y42.92%
EPS Next 3Y30.31%
EPS Next 5YN/A
Revenue Next Year12.6%
Revenue Next 2Y-1.85%
Revenue Next 3Y1.69%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XTNT Yearly Revenue VS EstimatesXTNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
XTNT Yearly EPS VS EstimatesXTNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • XTNT is valuated quite expensively with a Price/Earnings ratio of 58.76.
  • Based on the Price/Earnings ratio, XTNT is valued a bit cheaper than the industry average as 66.49% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of XTNT to the average of the S&P500 Index (26.64), we can say XTNT is valued expensively.
  • XTNT is valuated quite expensively with a Price/Forward Earnings ratio of 115.22.
  • Based on the Price/Forward Earnings ratio, XTNT is valued a bit cheaper than the industry average as 64.32% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, XTNT is valued quite expensively.
Industry RankSector Rank
PE 58.76
Fwd PE 115.22
XTNT Price Earnings VS Forward Price EarningsXTNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • XTNT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. XTNT is cheaper than 71.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.42
XTNT Per share dataXTNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as XTNT's earnings are expected to grow with 30.30% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y42.92%
EPS Next 3Y30.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • XTNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XTANT MEDICAL HOLDINGS INC

NYSEARCA:XTNT (2/23/2026, 8:22:43 PM)

0.5876

+0.01 (+1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10
Earnings (Next)03-05
Inst Owners57.21%
Inst Owner Change1.69%
Ins Owners16.56%
Ins Owner Change12.38%
Market Cap82.26M
Revenue(TTM)117.27M
Net Income(TTM)-4.58M
Analysts85
Price Target1.53 (160.38%)
Short Float %0.02%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.04%
Min EPS beat(2)100%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)77.12%
Min EPS beat(4)-56.86%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)73.86%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.07%
Min Revenue beat(2)3.39%
Max Revenue beat(2)10.74%
Revenue beat(4)2
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-6.52%
Max Revenue beat(4)10.74%
Revenue beat(8)6
Avg Revenue beat(8)5.84%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
Industry RankSector Rank
PE 58.76
Fwd PE 115.22
P/S 0.64
P/FCF N/A
P/OCF 54.81
P/B 1.7
P/tB 2.44
EV/EBITDA 24.42
EPS(TTM)0.01
EY1.7%
EPS(NY)0.01
Fwd EY0.87%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY1.82%
SpS0.91
BVpS0.35
TBVpS0.24
PEG (NY)0.48
PEG (5Y)N/A
Graham Number0.28
Profitability
Industry RankSector Rank
ROA -4.43%
ROE -9.44%
ROCE 0.04%
ROIC 0.03%
ROICexc 0.03%
ROICexgc 0.04%
OM 0.02%
PM (TTM) N/A
GM 60.16%
FCFM N/A
ROA(3y)-10.3%
ROA(5y)-11.34%
ROE(3y)-20.61%
ROE(5y)-25.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-2.41%
F-Score5
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 4.97
Cap/Depr 97.07%
Cap/Sales 3.39%
Interest Coverage 0.01
Cash Conversion 33.42%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.16
Altman-Z -0.81
F-Score5
WACC11.17%
ROIC/WACC0
Cap/Depr(3y)93.26%
Cap/Depr(5y)102.58%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y121.25%
EPS Next 2Y42.92%
EPS Next 3Y30.31%
EPS Next 5YN/A
Revenue 1Y (TTM)28.44%
Revenue growth 3Y28.5%
Revenue growth 5Y12.64%
Sales Q2Q%19.04%
Revenue Next Year12.6%
Revenue Next 2Y-1.85%
Revenue Next 3Y1.69%
Revenue Next 5YN/A
EBIT growth 1Y100.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year220.68%
EBIT Next 3Y42.24%
EBIT Next 5YN/A
FCF growth 1Y74.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.46%
OCF growth 3YN/A
OCF growth 5YN/A

XTANT MEDICAL HOLDINGS INC / XTNT FAQ

Can you provide the ChartMill fundamental rating for XTANT MEDICAL HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to XTNT.


What is the valuation status for XTNT stock?

ChartMill assigns a valuation rating of 4 / 10 to XTANT MEDICAL HOLDINGS INC (XTNT). This can be considered as Fairly Valued.


How profitable is XTANT MEDICAL HOLDINGS INC (XTNT) stock?

XTANT MEDICAL HOLDINGS INC (XTNT) has a profitability rating of 3 / 10.


What is the financial health of XTANT MEDICAL HOLDINGS INC (XTNT) stock?

The financial health rating of XTANT MEDICAL HOLDINGS INC (XTNT) is 3 / 10.


What is the expected EPS growth for XTANT MEDICAL HOLDINGS INC (XTNT) stock?

The Earnings per Share (EPS) of XTANT MEDICAL HOLDINGS INC (XTNT) is expected to grow by 121.25% in the next year.